MedTrace Logo

Multiple CoolSculpting Treatment Study

NCT01814007 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2021-05-17

Study results available
· View outcomes & findings →

Summary

To evaluate the safety of same-day CoolSculpting treatments and to assess the impact on serum lipids and liver-related tests.

Conditions

  • Body Fat Disorder

Interventions

DEVICE

The Zeltiq CoolSculpting System

Non-invasive cooling is applied to the treatment area with a defined cooling rate and duration.

Sponsors & Collaborators

  • Zeltiq Aesthetics

    lead INDUSTRY

Principal Investigators

  • Eric Bachelor, MD · Innovation Research Center

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2013-07-22
Completion
2013-10-22
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01814007 on ClinicalTrials.gov